BioMed Realty Trust Gets LEED Gold Certification at Center for Life Science | Boston

BioMed Realty Trust, Inc. announced today that the world's leading life science research center - the Center for Life Science | Boston in the Longwood Medical Area - has achieved Gold LEED certification for Core and Shell from the U.S. Green Building Council (USGBC).

The property is 91 percent leased to Beth Israel Deaconess Medical Center, Children's Hospital Boston, Dana Farber Cancer Institute, Immune Disease Institute, and Kowa Company, Ltd.

By granting the designation, the USGBC recognized the Center for Life Science | Boston for its design excellence in five key areas of human and environmental health: sustainable site development, water savings, energy efficiency, materials selection and indoor environmental quality.

The Center for Life Science | Boston is a 700,000+ square foot research center that includes laboratory and office space in the heart of Boston's Longwood Medical Area, surrounded by world class life science research institutions, hospitals, and biotechnology and pharmaceutical companies, including Harvard Medical School, Brigham and Women's Hospital, and Merck Research Laboratories Boston, along with the premier life science tenants of the Center for Life Science | Boston.

Commenting on the company's latest LEED certification, Alan D. Gold, BioMed's Chairman and Chief Executive Officer, said, "I congratulate Team BioMed and all of our development partners at the Center for Life Science | Boston for this important accomplishment. Our business model is focused on building a world-class property portfolio in the seven core U.S. life science markets. Creating a successful, sustainable business extends to the buildings that we develop. Along with our tenants, we have worked hard to develop state-of-the-art research facilities that also meet the rigorous requirements of the USGBC's LEED certification program."

In addition, BioMed is in the process of obtaining LEED certification for its 675 West Kendall Street building in Cambridge, Massachusetts which is 100 percent leased to Vertex Pharmaceuticals, and is targeting Gold LEED certification.

Kent Griffin, BioMed's President and Chief Financial Officer, remarked, "With Gold certification for the Center for Life Science | Boston, we now have more than 1.2 million square feet of LEED-certified laboratory and office space in the Cambridge/Boston market. We are seeing increased interest from prospective tenants in 'green' buildings, along with recent attention from state and federal government agencies that can provide financial support and other subsidies for life science organizations that occupy properties which include green/sustainable design elements."

((Comments on this story may be sent to newsdesk@closeupmedia.com))

Related terms: art, biotechnology, business, cancer, ceo, children, energy efficiency, environmental impact, federal, gold, government, hospital, israel, market, massachusetts, medical, pharmaceuticals, president, property, research, science, water, women